Global Central Nervous System Drugs Market Report 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Central Nervous System Drugs Global Market Report 2019” report has been added to ResearchAndMarkets.com’s offering.

Global Central Nervous System Drugs Market Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.

Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Central Nervous System Drugs market global report answers all these questions and many more.

The central nervous system drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that produce central nervous system drugs to treat brain and spinal cord diseases. This industry includes establishments that produce nervous system drugs, pain reducing analgesics, anti-Parkinson drugs to treat Parkinson’s disease, anticonvulsant anti-epileptics drugs to control epileptic seizures, anesthetics and other drugs such as muscle relaxants, antiemetics.

North America was the largest region in the global central nervous system drugs market, accounting for 43% of the market in 2018. Asia Pacific was the second largest region accounting for 24% of the global central nervous system drugs market. Africa was the smallest region in the global central nervous system drugs market.

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%.

For instance, in 2017, Michael J. Fox Foundation for Parkinson’s Research collaborated with specialty drugmaker Cynapsus Therapeutics and Intel to integrate wearable technology in a Phase-III clinical trial of APL-130277, an experimental drug for Parkinson’s disease. Biogen, a leading CNS drugmaker is using Fitbit, a smart wearable tracker, to better understand multiple sclerosis in patient studies, and the technology is expected to extend in Alzheimer’s disease research.

Key Topics Covered:

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Central Nervous System Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value ($ Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value ($ Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis

9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)

9.2. Global Central Nervous System Drugs Market, 2014 – 2022, Historic And Forecast, By Region

9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation

10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014 – 2022, Value ($ Billion)

10.1.1. Nervous System Drugs

10.1.2. Analgesics

10.1.3. Anti-Parkinson drugs

10.1.4. Anesthetics

10.1.5. Anti-Epileptics

10.1.6. Other CNS drugs

11. Central Nervous System Drugs Market Metrics

11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 – 2022, Global

11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 – 2022, Global

Companies Mentioned

• Biogen Inc
• F. Hoffmann-La Roche Ltd
• Johnson & Johnson
• Pfizer Inc
• Novartis AG

For more information about this report visit https://www.researchandmarkets.com/r/k0ilos

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics: Central Nervous System Drugs